Quality Overall Summary - Chemical Entities Clinical Trial Applications Phase III (QOS-CE (CTA - Phase III) (English, HTML)
View metadata and access the original English HTML file: Quality Overall Summary - Chemical Entities Clinical Trial Applications Phase III (QOS-CE (CTA - Phase III).
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2021-06-02
To assist submission sponsors in preparing Clinical Trial Applications (CTAs) filed with Health Canada by outlining the Quality (chemistry and manufacturing) technical requirements for CTAs pursuant to Division C.05 of the Food and Drug Regulations.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file